Understanding how RNA affects cell identity and development
DEFINING THE ROLE OF RNA SEQUESTRATION IN MAMMALIAN CELL FATE
This study is looking at how certain RNA molecules help cells know what type they should be and how they stay that way, which could lead to new treatments for conditions like cancer and ways to help the body heal itself.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10877790 on NIH RePORTER |
What this research studies
This research investigates the role of RNA sequestration in determining how cells develop and maintain their identity. By examining post-transcriptional mechanisms, the study aims to uncover how these processes influence cell fate during embryonic development and tissue homeostasis. The researchers will track changes in gene expression and cell behavior in early embryos when RNA sequestration is disrupted, providing insights that could lead to new therapies for regenerative medicine and cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in the underlying mechanisms of cell development and those affected by conditions related to cell identity and cancer.
Not a fit: Patients with established conditions that do not involve cell fate transitions or post-transcriptional regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapeutic strategies for regenerative medicine and cancer treatment.
How similar studies have performed: While the specific focus on RNA sequestration in mammalian cell fate is relatively novel, similar approaches in understanding gene expression regulation have shown promise in other studies.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Di Stefano, Bruno — Baylor College of Medicine
- Study coordinator: Di Stefano, Bruno
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.